Atlas Trials

KD Treatment for Super-refractory Status Epilepticus

Clinical trial NCT07496749 · RECRUITING

Trial details

NCT number
NCT07496749
Sponsor
Xuanwu Hospital, Beijing
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Super-refractory Status Epilepticus
Start date
2025-10-20
Primary completion
2027-02-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.